Dexmethylphenidate

In the US, Dexmethylphenidate (dexmethylphenidate systemic) is a member of the drug class CNS stimulants and is used to treat ADHD and Auditory Processing Disorder.

US matches:

• Dexmethylphenidate


• Dexmethylphenidate Extended-Release Capsules


• Dexmethylphenidate Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N06BA,N06BA11

CAS registry number (Chemical Abstracts Service)

0040431-64-9

Chemical Formula

C14-H19-N-O2

Molecular Weight

233

Therapeutic Category

Central stimulant

Chemical Names

(R)-Phenyl-[(R)-piperidin-2-yl]essigsäuremethylester (IUPAC)

2-Piperidineacetic acid, α-phenyl-, methyl ester, d-isomer

Methyl(2R)-phenyl[(2R)-piperidyl]acetate (WHO)

Foreign Names

• Dexmethylphenidatum (Latin)
• Dexmethylphenidat (German)
• Dexméthylphénidate (French)
• Dexmetilfenidato (Spanish)

Generic Names

• D 2785 (IS)
• d-methylphenidate (IS)
• d-MPH (IS)
• d-threo-methylphenidate (IS)
• Dexmethylphendidate Hydrochloride (OS: USAN)

Brand Names

• Dexmethylphenidate Hydrochloride
  Teva USA, United States



• Focalin
  Novartis, Switzerland; Novartis, United States



• Medikinet
  Medice, Luxembourg



• Ritalin LA
  Novartis, New Zealand

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.